Subscribe to Newsletter
Subspecialties Retina, Imaging & Diagnostics, Business and Innovation

A Helping Hand

Credit: Collage images sourced from and

In an exciting follow up to “AI to Interpret,” published in The Ophthalmologist back in 2020, the first artificial intelligence (AI) platform for OCT scan analysis has now launched online for public access with FDA clearance currently in process (1). The new Altris AI platform will help alleviate the compounded pressures of the fight against preventable blindness – affecting more than one billion people worldwide – and the global shortage of optometrists (2,3).

Able to detect more than 100 retina pathologies and pathological signs – both widespread and rare – and differentiate between pathological and non-pathological OCT scans within minutes, the new platform provides a promising decision making support tool to help ophthalmologists in their daily practice. Eye care specialists from 140 countries have already registered onto the platform and tested its benefits in clinical practice.

How was the AI model created? First, the Altris AI medical team collected and labeled thousands of OCT scans under my supervision. Our team of ten experts then marked pathologies and pathological signs on all OCT scans inside a special program, preparing them for the model. This activity was followed by the implementation and training of the AI model. Popular neural network architectures for medical imaging, such as UNet and FPn, were used as a starting point alongside necessary proprietary changes that ensured the model was both adaptable yet capable of handling the complex data involved.

This AI tool – along with many others –  is here to help clinicians, offering a second opinion on OCT scans and automating some of the most repetitive tasks of ophthalmology. More than this, the combined knowledge of eye care specialists and AI models may help to reduce human errors among less experienced eye care specialists.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. The Ophthalmologist, “AI to Interpret” (2020). Available at:
  2. UN News, “One Billion People Have Preventable Eye Conditions” (2019) Available at:
  3. World Economic Forum “Here’s How We Can Provide Better Eye Care for the World” (2022). Available at:
About the Author
Maria Znamenska

Maria Znamenska is Medical Director of Altris AI

Related Product Profiles
Uncover the Unique DNA of SPECTRALIS®

| Contributed by Heidelberg Engineering

Subspecialties Retina
ForeseeHome® – remote monitoring to help detect wet AMD earlier and improve outcomes

| Contributed by Notal Vision

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: